AbCellera Biologics Inc.

An AI-powered platform that discovers and develops antibody therapeutics for pharma partners.

ABCL | NDAQ

Overview

Corporate Details

ISIN(s):: N/A
LEI:
Country:: United States of America
Address:: 150 W 4TH AVENUE, VANCOUVER
Website:: https://www.abcellera.com/
Sector:: Mining and quarrying
Industry:: Mining of non-ferrous metal ores

Description

AbCellera Biologics Inc. is a clinical-stage biotechnology company that discovers and develops antibody-based therapeutics. The company operates a proprietary, AI-powered drug discovery platform that integrates advanced technologies in biology, computation, and engineering. This full-stack platform is designed to search, decode, and analyze natural immune systems at high speed and scale to find novel antibodies for therapeutic development. AbCellera partners with pharmaceutical and biotech companies to advance a pipeline of first-in-class and best-in-class antibody programs across various therapeutic areas, including cancer and endocrinology. The platform supports the development of complex modalities, such as bispecifics and antibody-drug conjugates, for conditions with high unmet medical need.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all AbCellera Biologics Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for AbCellera Biologics Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for AbCellera Biologics Inc. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
Anixa Biosciences Inc Clinical-stage biotech developing CAR-T immunotherapies and vaccines to fight cancer.	United States of America	ANIX
Annovis Bio, Inc. Developing oral therapies for neurodegenerative diseases like Alzheimer's and Parkinson's.	United States of America	ANVS
Aoyama Zaisan Networks Company,Limited Consulting on inheritance and business succession for individuals and corporations.	Japan	8929
APG SGA SA Switzerland's leading OOH media firm offering digital and analogue outdoor advertising solutions.	Switzerland	APGN.SW
APURES CO., LTD. Biotech R&D using a miniature pig model, offering CRO services and biomaterials to pharma.	South Korea	149300
ARM HOLDINGS PLC /UK Licenses energy-efficient CPU IP for AI, mobile, automotive, IoT, and cloud markets.	United States of America	ARM
Arterra Bioscience Develops natural active ingredients via biotechnology for cosmetic, pharma, and food sectors.	Italy	ABS
ARVINAS, INC. Develops protein degradation drugs for oncology & neuroscience, targeting undruggable proteins.	United States of America	ARVN
ASUA Inc. Consulting and solutions provider enhancing logistics safety and efficiency with IoT and telecom.	Japan	246A
Atomera Inc Licenses semiconductor material and IP to enhance transistor performance and power efficiency.	United States of America	ATOM